BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23290254)

  • 1. Carbonic anhydrase inhibitors: benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII.
    Alafeefy AM; Isik S; Abdel-Aziz HA; Ashour AE; Vullo D; Al-Jaber NA; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1396-403. PubMed ID: 23290254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
    Nocentini A; Carta F; Ceruso M; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2015 Nov; 23(21):6955-66. PubMed ID: 26432607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
    Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
    Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
    Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
    Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
    Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
    Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Ibrahim DA; Lasheen DS; Zaky MY; Ibrahim AW; Vullo D; Ceruso M; Supuran CT; Abou El Ella DA
    Bioorg Med Chem; 2015 Aug; 23(15):4989-4999. PubMed ID: 26048024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Güzel-Akdemir Ö; Akdemir A; Karalı N; Supuran CT
    Org Biomol Chem; 2015 Jun; 13(23):6493-9. PubMed ID: 25967275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.
    Rami M; Maresca A; Smaine FZ; Montero JL; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2011 May; 21(10):2975-9. PubMed ID: 21470859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides.
    Métayer B; Mingot A; Vullo D; Supuran CT; Thibaudeau S
    Chem Commun (Camb); 2013 Jul; 49(54):6015-7. PubMed ID: 23503420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII.
    Bozdag M; Alafeefy AM; Altamimi AM; Carta F; Supuran CT; Vullo D
    Bioorg Med Chem; 2017 May; 25(10):2782-2788. PubMed ID: 28389112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.